Table 1 Characteristics of HIV-HBV coinfected and HBV monoinfected patients

Age (year) (median (IQR))

52(46–61)

48.5 (35–55)

Male (n (%))

7(100%)

103 (87.29%)

Indication (n (%))

Liver failure

6(85.7%)

73(61.86%)

Decompensated liver cirrhosis

1(14.3%)

45(38.14%)

Detectable HBV DNA pre-OLT (n (%))

4(57.1%)

101(85.59%)

MELD score (median (IQR))

34(31–40)

31(18-39.25)

CD4 cell count pre-OLT (cells/ul) (median (IQR))

121(42–165)

256.5(146.25–476.5)

Acute rejection (n (%))

1(14.3%)

5 (4.24%)

Complications (n (%))

Bacteremia

1(14.3%)

10 (8.47%)

CMV infection

5 (71.43%)

47(39.83%)

Pulmonary infection

2(28.57%)

34 (28.81%)

Acute kidney injury

1(14.3%)

7(5.93%)

De novo malignancies

0

2(1.69%)

Biliary complications

0

6(5.08%)

Artery complications

0

2

Hepatic venous complications

0

1

Portal vein thrombosis

0

2(1.69%)

Length of hospital stay post-OLT (median (IQR))

37(31–64)

26.5 (20.75-35)

Duration of follow-up after LT (month)

36(12–39)

23.5(12.9–33.4)